Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1996 Dec;104(Suppl 6):1189–1193. doi: 10.1289/ehp.961041189

Investigation of the DNA adducts formed in B6C3F1 mice treated with benzene: implications for molecular dosimetry.

W J Bodell 1, D N Pathak 1, G Lévay 1, Q Ye 1, K Pongracz 1
PMCID: PMC1469766  PMID: 9118892

Abstract

We have investigated the formation of DNA adducts in the bone marrow and white blood cells of male B6C3F1 mice treated with benzene using P1-enhanced 32P-postlabeling. No adducts were detected in the bone marrow of controls or mice treated with various doses of benzene once a day. After twice-daily treatment for 1 to 7 days with benzene, 440 mg/kg, one major (no. 1) and up to two minor DNA adducts were detected in both the bone marrow and white blood cells. The relative adduct levels in these cells ranged from 0.06 to 1.46 x 10(-7). a significant correlation (r2 = 0.95) between levels of adducts in bone marrow and white blood cells was observed. After a 7-day treatment with benzene, 440 mg/kg twice a day, the number of cells per femur decreased from 1.6 x 10(7) to 0.85 x 10(7), indicating myelotoxicity. In contrast, administration of benzene once a day produced only a small decrease in bone marrow cellularity. The observed induction of toxicity in bone marrow was paralleled by formation of DNA adducts. In vitro treatment of bone marrow with hydroquinone (HQ) for 24 hr produced the same DNA adducts as found after treatment of mice with benzene, suggesting that HQ is the principal metabolite of benzene leading to DNA adduct formation in vivo. Using P-postlabeling the principal DNA adduct formed in vivo was compared with N2-(4-hydroxyphenyl)-2'-deoxyguanosine-3'-phosphate. The results of this comparison demonstrated that the DNA adduct formed in vivo co-chromatographs with N2-(4-hydroxyphenyl)-2'-deoxyguanosine-3'-phosphate. These studies indicate that metabolic activation of benzene leads to the formation of DNA adducts in bone marrow and white blood cells and suggest that measurement of DNA adducts in white blood cells may be an indicator of biological effect following benzene exposure.

Full text

PDF
1189

Images in this article

1190Figure 1. A
on p.1190
1190Figure 1. B
on p.1190
1190Figure 1. C
on p.1190
1190Figure 1. D
on p.1190
1190Figure 2.
on p.1190
1191Figure 3. A
on p.1191
1191Figure 3. B
on p.1191
1191Figure 4. A
on p.1191
1191Figure 4. B
on p.1191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews L. S., Lee E. W., Witmer C. M., Kocsis J. J., Snyder R. Effects of toluene on the metabolism, disposition and hemopoietic toxicity of [3H]benzene. Biochem Pharmacol. 1977 Feb 15;26(4):293–300. doi: 10.1016/0006-2952(77)90180-0. [DOI] [PubMed] [Google Scholar]
  2. Arfellini G., Grilli S., Colacci A., Mazzullo M., Prodi G. In vivo and in vitro binding of benzene to nucleic acids and proteins of various rat and mouse organs. Cancer Lett. 1985 Sep 15;28(2):159–168. doi: 10.1016/0304-3835(85)90071-0. [DOI] [PubMed] [Google Scholar]
  3. Bauer H., Dimitriadis E. A., Snyder R. An in vivo study of benzene metabolite DNA adduct formation in liver of male New Zealand rabbits. Arch Toxicol. 1989;63(3):209–213. doi: 10.1007/BF00316370. [DOI] [PubMed] [Google Scholar]
  4. Eastmond D. A., Smith M. T., Ruzo L. O., Ross D. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase. Mol Pharmacol. 1986 Dec;30(6):674–679. [PubMed] [Google Scholar]
  5. Goldstein B. D. Benzene toxicity: a critical evaluation: hematotoxicity in humans. J Toxicol Environ Health Suppl. 1977;2:69–105. [PubMed] [Google Scholar]
  6. Greenlee W. F., Gross E. A., Irons R. D. Relationship between benzene toxicity and the disposition of 14C-labelled benzene metabolites in the rat. Chem Biol Interact. 1981 Jan;33(2-3):285–299. doi: 10.1016/0009-2797(81)90047-8. [DOI] [PubMed] [Google Scholar]
  7. Guengerich F. P., Kim D. H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991 Mar-Apr;4(2):168–179. doi: 10.1021/tx00020a008. [DOI] [PubMed] [Google Scholar]
  8. Kalf G. F. Recent advances in the metabolism and toxicity of benzene. Crit Rev Toxicol. 1987;18(2):141–159. doi: 10.3109/10408448709089859. [DOI] [PubMed] [Google Scholar]
  9. Kolachana P., Subrahmanyam V. V., Meyer K. B., Zhang L., Smith M. T. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 1993 Mar 1;53(5):1023–1026. [PubMed] [Google Scholar]
  10. Latriano L., Goldstein B. D., Witz G. Formation of muconaldehyde, an open-ring metabolite of benzene, in mouse liver microsomes: an additional pathway for toxic metabolites. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8356–8360. doi: 10.1073/pnas.83.21.8356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levay G., Pongracz K., Bodell W. J. Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling. Carcinogenesis. 1991 Jul;12(7):1181–1186. doi: 10.1093/carcin/12.7.1181. [DOI] [PubMed] [Google Scholar]
  12. Lutz W. K., Schlatter C. Mechanism of the carcinogenic action of benzene: irreversible binding to rat liver DNA. Chem Biol Interact. 1977 Aug;18(2):241–245. doi: 10.1016/0009-2797(77)90010-2. [DOI] [PubMed] [Google Scholar]
  13. Lévay G., Bodell W. J. Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7105–7109. doi: 10.1073/pnas.89.15.7105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lévay G., Ross D., Bodell W. J. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis. 1993 Nov;14(11):2329–2334. doi: 10.1093/carcin/14.11.2329. [DOI] [PubMed] [Google Scholar]
  15. Mazzullo M., Bartoli S., Bonora B., Colacci A., Grilli S., Lattanzi G., Niero A., Turina M. P., Parodi S. Benzene adducts with rat nucleic acids and proteins: dose-response relationship after treatment in vivo. Environ Health Perspect. 1989 Jul;82:259–266. doi: 10.1289/ehp.8982259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McDonald T. A., Yeowell-O'Connell K., Rappaport S. M. Comparison of protein adducts of benzene oxide and benzoquinone in the blood and bone marrow of rats and mice exposed to [14C/13C6]benzene. Cancer Res. 1994 Sep 15;54(18):4907–4914. [PubMed] [Google Scholar]
  17. Pathak D. N., Lévay G., Bodell W. J. DNA adduct formation in the bone marrow of B6C3F1 mice treated with benzene. Carcinogenesis. 1995 Aug;16(8):1803–1808. doi: 10.1093/carcin/16.8.1803. [DOI] [PubMed] [Google Scholar]
  18. Pongracz K., Bodell W. J. Detection of 3'-hydroxy-1,N6-benzetheno-2'-deoxyadenosine 3'-phosphate by 32P postlabeling of DNA reacted with p-benzoquinone. Chem Res Toxicol. 1991 Mar-Apr;4(2):199–202. doi: 10.1021/tx00020a012. [DOI] [PubMed] [Google Scholar]
  19. Pongracz K., Bodell W. J. Synthesis of N2-(4-hydroxyphenyl)-2'-deoxyguanosine 3'-phosphate: comparison by 32P-postlabeling with the DNA adduct formed in HL-60 cells treated with hydroquinone. Chem Res Toxicol. 1996 Apr-May;9(3):593–598. doi: 10.1021/tx9500991. [DOI] [PubMed] [Google Scholar]
  20. Pongracz K., Kaur S., Burlingame A. L., Bodell W. J. Detection of (3'-hydroxy)-3,N4-benzetheno-2'-deoxycytidine-3'-phosphate by 32P-postlabeling of DNA reacted with p-benzoquinone. Carcinogenesis. 1990 Sep;11(9):1469–1472. doi: 10.1093/carcin/11.9.1469. [DOI] [PubMed] [Google Scholar]
  21. Reddy M. V., Blackburn G. R., Schreiner C. A., Mehlman M. A., Mackerer C. R. 32P analysis of DNA adducts in tissues of benzene-treated rats. Environ Health Perspect. 1989 Jul;82:253–257. doi: 10.1289/ehp.8982253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Reddy M. V., Bleicher W. T., Blackburn G. R., Mackerer C. R. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates. Carcinogenesis. 1990 Aug;11(8):1349–1357. doi: 10.1093/carcin/11.8.1349. [DOI] [PubMed] [Google Scholar]
  23. Reddy M. V., Schultz S. C., Blackburn G. R., Mackerer C. R. Lack of DNA adduct formation in mice treated with benzene. Mutat Res. 1994 Dec;325(4):149–155. doi: 10.1016/0165-7992(94)90078-7. [DOI] [PubMed] [Google Scholar]
  24. Rickert D. E., Baker T. S., Bus J. S., Barrow C. S., Irons R. D. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol. 1979 Jul;49(3):417–423. doi: 10.1016/0041-008x(79)90441-1. [DOI] [PubMed] [Google Scholar]
  25. Rinsky R. A., Smith A. B., Hornung R., Filloon T. G., Young R. J., Okun A. H., Landrigan P. J. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med. 1987 Apr 23;316(17):1044–1050. doi: 10.1056/NEJM198704233161702. [DOI] [PubMed] [Google Scholar]
  26. Sabourin P. J., Bechtold W. E., Griffith W. C., Birnbaum L. S., Lucier G., Henderson R. F. Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol Appl Pharmacol. 1989 Jul;99(3):421–444. doi: 10.1016/0041-008x(89)90151-8. [DOI] [PubMed] [Google Scholar]
  27. Sadler A., Subrahmanyam V. V., Ross D. Oxidation of catechol by horseradish peroxidase and human leukocyte peroxidase: reactions of o-benzoquinone and o-benzosemiquinone. Toxicol Appl Pharmacol. 1988 Mar 30;93(1):62–71. doi: 10.1016/0041-008x(88)90025-7. [DOI] [PubMed] [Google Scholar]
  28. Sammett D., Lee E. W., Kocsis J. J., Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J Toxicol Environ Health. 1979 Sep;5(5):785–792. doi: 10.1080/15287397909529789. [DOI] [PubMed] [Google Scholar]
  29. Schlosser M. J., Shurina R. D., Kalf G. F. Prostaglandin H synthase catalyzed oxidation of hydroquinone to a sulfhydryl-binding and DNA-damaging metabolite. Chem Res Toxicol. 1990 Jul-Aug;3(4):333–339. doi: 10.1021/tx00016a010. [DOI] [PubMed] [Google Scholar]
  30. Schlosser P. M., Bond J. A., Medinsky M. A. Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis. 1993 Dec;14(12):2477–2486. doi: 10.1093/carcin/14.12.2477. [DOI] [PubMed] [Google Scholar]
  31. Snyder R., Kalf G. F. A perspective on benzene leukemogenesis. Crit Rev Toxicol. 1994;24(3):177–209. doi: 10.3109/10408449409021605. [DOI] [PubMed] [Google Scholar]
  32. Subrahmanyam V. V., Kolachana P., Smith M. T. Metabolism of hydroquinone by human myeloperoxidase: mechanisms of stimulation by other phenolic compounds. Arch Biochem Biophys. 1991 Apr;286(1):76–84. doi: 10.1016/0003-9861(91)90010-g. [DOI] [PubMed] [Google Scholar]
  33. Wallace L. A. Major sources of benzene exposure. Environ Health Perspect. 1989 Jul;82:165–169. doi: 10.1289/ehp.8982165. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES